Shield Progress Draws Attention To Guardant Health's Valuation And Risks [Yahoo! Finance]
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Guardant Health's Shield blood-based colorectal cancer test was recently included in updated National Comprehensive Cancer Network screening guidelines. A new national survey of Americans aged 45 and over shows strong support for broader insurance coverage of blood-based colorectal cancer screening. The company has launched the Shield Across America mobile tour to expand access to blood-based screening across the country, with a focus on underserved communities. Guardant Health (NasdaqGS:GH), trading at $85.49, is drawing attention as it builds out its presence in colorectal cancer screening through Shield. The stock has seen a very large 3 year gain of 206.0%, alongside a 1 year return of 99.3%. This comes even as the share price has declined 16.0% year to date and 18.5% over the past month. Those mixed returns frame a company that has a
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Franklin DynaTech Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
- 3 Reasons to Avoid GH and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Why Guardant Health's (GH) 2026 Screening Story Reinforced Piper Sandler's Bullish View [Yahoo! Finance]Yahoo! Finance
- Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 [Yahoo! Finance]Yahoo! Finance
- Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026Business Wire
GH
Earnings
- 2/19/26 - Beat
GH
Sec Filings
- 3/23/26 - Form 4
- 3/19/26 - Form 4
- 3/18/26 - Form 4
- GH's page on the SEC website